期刊文献+

间变性淋巴瘤激酶阳性肺腺癌细胞病理学特点初探 被引量:2

Anaplastic lymphoma kinase-positive adenocarcinoma of lung : a cytopathologic analysis
原文传递
导出
摘要 目的探讨间变性淋巴瘤激酶(ALK)基因重排阳性肺腺癌的细胞病理学特点。方法回顾性分析2011年9月至2015年4月在复旦大学附属肿瘤医院用细胞学标本进行AIⅨ基因重排和/或ALK融合蛋白检测的肺腺癌连续病例153例,包括胸水34例,经气管镜超声引导针吸活检术(EBUS.TBNA)40例,体表肿块穿刺79例。结果经荧光原位杂交(FISH)和免疫组织化学VentanaALK(D5F3)证实的ALK阳性病例共39例(25.5%),其中单独由FISH法确定的3例,经两者共同证实的36例。中位年龄50岁,较ALK阴性者(60岁)年轻(P=0.002)。39例ALK阳性患者中只有4例为吸烟者,明显少于阴性组(P〈0.01)。ALK阳性病例中3例可见筛孑L状结构和明显的核仁,3例见筛孔状结构和黏液细胞,8例见细胞外黏液和黏液细胞,出现率显著高于ALK阴性病例(均P〈0.01)。结论细胞学标本(常规涂片和细胞块)可以显示ALK阳性肺腺癌的一些形态学特征如筛孔状结构、明显的核仁、黏液细胞和细胞外黏液等,结合患者临床特征,对于筛选潜在ALK阳性的肺腺癌患者有一定帮助。 Objective To study the cytomorphologic features of anaplastic lymphoma kinase (ALK)-rearranged pulmonary adenocarcinoma. Methods The morphologic features in 153 pulmonary adenocarcinoma cytology specimens encountered during the period from September, 2011 to April, 2015 in Shanghai Cancer Hospital were retrospectively reviewed. Fluorescence in-situ hybridization (FISH) and/or immunohistochemistry (Ventana DSF3) for ALK gene rearrangement were carried out. The samples studied included 34 pleural effusion specimens, 40 endobronchial ultrasound-guided transbronchial needle aspirates (EBUS-TBNA) and 79 fine needle aspirates of palpable masses on body surface. Results Thirty-nine cases (25.5%) of ALK-rearranged samples were identified by FISH and/or immunohistochemistry, including 3 cases diagnosed by FISH and 36 cases by both technologies. The median age of the ALK-positive group was 50 years, significantly younger than that of the ALK-negative group (60 years old,P = 0. 002). Only 4 of the ALK-positive patients were smokers, which was significantly less than that of the ALK-negative group (P 〈0. 01 ). In ALK-positive group, 3 cases showed cribriform pattern with prominent nucleoli, 3 cases showed cribriform pattern with mucin-rich cells and 8 cases showed extracellular mucus with mucin-rich cells. The above cytomorphologic patterns were significantly less common in ALK-negative tumors (P 〈 0.01). Conclusions ALK-rearranged lung adenocarcinoma is associated with certain distinctive morphologic patterns, including cribriform architecture, presence of prominent nucleoli, mucin-rich cells and extracellular mucus, which can be observed in cytology specimens ( including conventional smears and cell block sections). These findings, when combined with clinical features, may give clues to detection of ALK- positive cases.
出处 《中华病理学杂志》 CAS CSCD 北大核心 2015年第9期628-632,共5页 Chinese Journal of Pathology
关键词 肺肿瘤 腺癌 活组织检查 针吸 原位杂交 荧光 细胞诊断学 Lung neoplasms Adenocarcinoma Biopsy, needle In situ hybridization,fluorescence Cytodiagnosis
  • 相关文献

参考文献13

  • 1Soda M, Choi YL, Enomoto M, et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer [J]. Nature, 2007,448(7153) :561-566.
  • 2Rikova K, Guo A, Zeng Q, et al. Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer [ J 1-Cell, 2007,131(6) :1190-1203.
  • 3Shaw AT, Yeap BY, Mino-Kenudson M, et al. Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK [ J ]. J Clin Oncol, 2009,27 (26) :4247-4253.
  • 4Li Y, Pan Y, Wang R, et al. ALK-rearranged lung cancer in Chinese: a comprehensive assessment of clinicopathology, IHC, FISH and RT-PCR[J~. PLoS One, 2013,8(7) :e69016.
  • 5张绪超,陆舜,张力,王长利,程颖,李甘地,Tony Mok,Mok,黄诚,刘晓晴,王洁,王孟昭,张沂平,周建英,周晓燕,林冬梅,杨衿记,李慧,陈海泉,钟文昭,吴一龙.中国间变性淋巴瘤激酶(ALK)阳性非小细胞肺癌诊断专家共识(2013版)[J].中华病理学杂志,2013,42(6):402-406. 被引量:93
  • 6Rekhtman N, Brandt SM, Sigel CS, et al. Suitability of thoracic cytology for new therapeutic paradigms in non-small cell lung carcinoma: high accuracy of tumor subtyping and feasibility of EGFR and KRAS molecular testing[ J 1. J Thorac Oncol, 2011,6 (3) :451-458. .
  • 7Malapelle U, Bellevieine C, Zeppa P,et al. Cytology-based gene mutation tests to predict response to anti-epidermal growth factor receptor therapy : a review[ J]. Diagn Cytopathol, 2011,39 ( 9 ) : 703-710.
  • 8Camidge DR, Skokan M, Kiatsimkul P, et al. Native and rearranged ALK copy number and rearranged cell count in non- small cell lung cancer: implications for ALK inhibitor therapy [ J l- Cancer, 2013,119(22) :3968-3975.
  • 9Wang W, Tang Y, Li J, et al. Detection of ALK rearrangements in malignant pleural effusion cell blocks from patients with advanced non-smallcell lung cancer: a comparison of Ventana immunohistochemistry and fluorescence in situ hybridization [ J ]. Cancer Cytopathol, 2015, 123(2) :117-122.
  • 10Yoshida A, Tsuta K, Nakamura H, et al. Comprehensive histologic analysis of ALK-rean'anged lung carcinomas [ J ]. Am J Surg Pathol, 2011,35 ( 8 ) : 1226-1234.

二级参考文献27

  • 1Soda M,Choi YL,Enomoto M,et al.Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.Nature,2007,448(7153):561-566.
  • 2Wong DW,Leung EL,So KK,et al.The EML4 ALK fusion gene is involved in various histologic types of lung cancers from nonsmokers with wild-type EGFR and KRAS.Cancer,2009,115(8):1723-1733.
  • 3Shaw AT,Yeap BY,Mino-Kenudson M,et al.Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK.J Clin Oncol,2009,27(26):4247-4253.
  • 4Shaw AT.Phase 3 randomized study of crizotinib versus pemetrexed or docetaxel chemotherapy in advanced,ALK-positive NSCLC (PROFILE 1007).35th ESMO,2012,abstract LBA1.
  • 5全国肿瘤防治研究办公室/全国肿瘤登记中心/卫生部疾病预防控制局.2009全国肿瘤登记年报.北京:军事医学科学出版社.2010.
  • 6Rikova K,Guo A,Zeng Q,et al.Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer.Cell,2007,131 (6):1190-1203.
  • 7Mitsudomi T,Suda K,Tomizawa K,et al.Clinico-pathologic features of lung cancer with EML4-ALK translocation.J Clin Oncol,2010 (suppl):abstr 10598.
  • 8Zhang X,Zhang S,Yang X,et al.Fusion of EML4 and ALK is associated with development of lung adenocarcinomas lacking EGFR and KRAS mutations and is correlated with ALK expression.Mol Cancer,2010,9:188.
  • 9Wu SG,Kuo YW,Chang YL,et al.EML4-ALK translocation predicts better outcome in lung adenocarcinoma patients with wildtype EGFR.J Thorac Oucol,2012,7(1):98-104.
  • 10Rodig SJ,Mino-Kenudson M,Dacic S,et al.Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population.Clin Cancer Res,2009,15(16):5216-5223.

共引文献92

同被引文献17

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部